|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Straight-line revenue receivable | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Deferred income tax assets, net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Derivative asset | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders' Deficit: | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Settlement payable (Note 11) | ||||||||||||||||||||
| Intangible liabilities, net | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Derivative liability, net | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease obligations | ||||||||||||||||||||
| Notes and other debt, net | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Deficit: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value, 50,000 shares authorized, no shares issued and outstanding | ||||||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
| Common stock, $0.0001 par value, 500,000 shares authorized, issued and outstanding: 238,568 shares at June 30, 2025 and 237,513 shares at December 31, 2024 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Distributions in excess of accumulated earnings | ||||||||||||||||||||
| Total Uniti shareholders' deficit | ||||||||||||||||||||
| Noncontrolling interests: | ||||||||||||||||||||
| Operating partnership units | ||||||||||||||||||||
| Cumulative non-voting convertible preferred stock, $0.01 par value, 6 shares authorized, 3 issued and outstanding | ||||||||||||||||||||
| Total shareholders' deficit | ||||||||||||||||||||
| Total Liabilities and Shareholders' Deficit | ||||||||||||||||||||
Loading...
